Received: 4 June 2018
Accepted: 2 November 2018
First Online: 23 November 2018
Ethics approval and consent to participate
: Approval to conduct this study was obtained on an exempt basis from the John F. Wolfe Human Subjects Committee of the Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center (project number 20547–01).
: Not applicable.
: Neetu K. Sodhi, D.O., M.P.H. declares that they have no competing interests.Anita L. Nelson, MD declares the following competing interests: Grants/Research: Agile, ContraMed, Estetra PRL, Evofem Inc., FHI (MonaLisa), Mathra Pharma, Merck; Honoraria/Speakers Bureau: Allergan, Bayer, Merck; Consultant/Advisory Board: Agile, AMAG Pharma, Bayer, ContraMed, Merck, Pharmanest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.